Cargando…
Decreasing Poly(ADP-Ribose) Polymerase Activity Restores ΔF508 CFTR Trafficking
Most cystic fibrosis is caused by mutations in CFTR that prevent its trafficking from the ER to the plasma membrane and is associated with exaggerated inflammation, altered metabolism, and diminished responses to oxidative stress. PARP-1 is activated by oxidative stress and causes energy depletion a...
Autores principales: | Anjos, Suzana M., Robert, Renaud, Waller, Daniel, Zhang, Dong Lei, Balghi, Haouaria, Sampson, Heidi M., Ciciriello, Fabiana, Lesimple, Pierre, Carlile, Graeme W., Goepp, Julie, Liao, Jie, Ferraro, Pasquale, Phillipe, Romeo, Dantzer, Françoise, Hanrahan, John W., Thomas, David Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439826/ https://www.ncbi.nlm.nih.gov/pubmed/22988441 http://dx.doi.org/10.3389/fphar.2012.00165 |
Ejemplares similares
-
Ouabain Mimics Low Temperature Rescue of F508del-CFTR in Cystic Fibrosis Epithelial Cells
por: Zhang, Donglei, et al.
Publicado: (2012) -
Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines
por: Sampson, Heidi M, et al.
Publicado: (2013) -
A novel triple combination of pharmacological chaperones improves F508del-CFTR correction
por: Carlile, Graeme W., et al.
Publicado: (2018) -
Unravelling druggable signalling networks that control F508del-CFTR proteostasis
por: Hegde, Ramanath Narayana, et al.
Publicado: (2015) -
Combination of Selective PARP3 and PARP16 Inhibitory
Analogues of Latonduine A Corrects F508del-CFTR Trafficking
por: Centko, Ryan M., et al.
Publicado: (2020)